India Trauma Devices Market Overview, 2031

Key Insights

• India's trauma fixation market is experiencing robust growth, driven by a high incidence of road accidents, increasing sports injuries, and a rapidly growing geriatric population susceptible to osteoporotic fractures. The market encompasses internal fixation devices and external fixation systems, with internal devices holding a significant share due to better clinical outcomes and minimally invasive approaches.
• India faces a substantial trauma burden, with over 4.87 lakh road accidents recorded in 2024, resulting in approximately 20 deaths every hour. Although India has only 1% of the world's vehicle population, it accounts for nearly 11% of global road accident deaths about 1.77 lakh (177,000) fatalities annually. This persistent and high-volume trauma burden drives consistent demand for trauma fixation devices across the country.
• The Indian medical device regulatory landscape is evolving, with the Central Drugs Standard Control Organization implementing a risk-based classification system where orthopedic implants are classified as Class C. In November 2025, CDSCO issued a directive to hospitals not to discriminate against devices lacking USFDA or EU certification, reaffirming that CDSCO's own approval is the mandated requirement for importing, manufacturing, selling, and distributing medical devices in India.
• The market benefits from government initiatives under schemes like Ayushman Bharat and Make in India, which are encouraging local production and wider access to trauma care. Evidence from a Level-1 trauma centre shows that Ayushman card utilization increased orthopaedic trauma surgeries by 28.1%, from 2,526 to 3,236 cases between 2024 and 2025.

Market Outlook

• According to the research report, "India Trauma Devices Market Overview, 2031," published by Bonafide Research, the India Trauma Devices Market is anticipated to grow at more than 7.58% CAGR from 2026 to 2031.
• The India Trauma Fixation Market is poised for sustained expansion, underpinned by a powerful combination of demographic, economic, and infrastructural trends. The rising incidence of road accidents, sports injuries, and falls continues to drive core demand. Simultaneously, India's rapidly aging population, suffering from a higher prevalence of osteoporosis and bone disorders, is creating a significant and growing patient pool. Urbanization and growing awareness of trauma care are increasing patient inflow to private hospitals, while tier-II and tier-III cities are emerging as new growth frontiers.
• A fundamental shift is underway from conventional fixation methods to advanced internal fixation devices such as locking plates, nails, and bioabsorbable implants, supported by technological advancements and improved surgical techniques. Minimally invasive surgeries are gaining traction due to faster recovery times and reduced hospital stays. The adoption of 3D printing for customized implants and the rise of biodegradable fixation devices represent key technological trends shaping the market.

Policies

• The Central Drugs Standard Control Organization, under the Ministry of Health and Family Welfare, is the primary regulatory authority responsible for medical device registration, classification, and oversight in India. As of 2024-25, almost all medical device categories have undergone notification and regulation by the government.
• CDSCO requires registration and licensing for all medical devices marketed in India. Manufacturers of Class C devices must obtain a manufacturing license and product approval from CDSCO. In September 2025, CDSCO introduced a new online provision for "Subsequent Importer" applications, effective September 11, 2025, allowing companies to import medical devices already approved by CDSCO, aiming to simplify approvals, enhance transparency, and reduce processing timelines.
• The National Pharmaceutical Pricing Authority (NPPA) regulates the prices of orthopedic implants. In September 2025, NPPA extended the existing ceiling prices for orthopaedic knee implants until November 15, 2025. Orthopedic implants used in fractures, arthritis, and congenital skeletal issues are already under national price control, ensuring uniform ceiling prices across India.
• In a significant November 2025 development, CDSCO issued a directive to hospitals not to discriminate against medical devices lacking USFDA or EU certification. Drug Controller General of India emphasized that CDSCO's own approval granted after due diligence on safety and efficacy is the mandated requirement for importing, manufacturing, selling, and distributing any medical device in India. India imports approximately USD 8 billion worth of medical devices annually about two-thirds of the total domestic market.

Trauma Burden & Treatment Statistics

• India faces a substantial and growing trauma burden. In 2024, the number of road accidents increased by 1.48% to over 4.87 lakh, resulting in an average of 20 deaths every hour. Road accident deaths increased by 2.5% in 2024 compared to 2023, with hit and run cases recording the sharpest rise deaths increasing by 9.0% year-on-year to 34,030, accounting for 19.2% of all road fatalities.
• Although India has only 1% of the world's vehicle population, it accounts for nearly 11% of global road accident deaths approximately 1.77 lakh fatalities annually. Thousands continue to suffer life-altering injuries; Bengaluru alone recorded 4,022 injured persons in road crashes during 2024.
• Evidence from a Level-1 trauma centre in India shows the growing demand for trauma care: total trauma admissions rose from 3,378 in 2024 to 4,085 in 2025, reflecting a 20.9% increase in inpatient volume. Similarly, the number of orthopaedic trauma surgeries increased from 2,526 to 3,236, representing a 28.1% rise in operative workload.
• Government initiatives under Ayushman Bharat are improving access to orthopaedic trauma care. At a Level-1 trauma centre, the number of Ayushman cardholders increased from 936 in 2024 to 1,499 in 2025, with utilization among PM-JAY beneficiaries rising to 87.7%.

Segment Analysis

India Trauma Devices Market By Product Type
• Internal fixation devices are used in approximately 1.8-2.5 million orthopedic trauma procedures annually in India, including plates, screws, intramedullary nails, and locking fixation systems. High volume trauma hospitals typically maintain 40-80 fixation implant configurations to manage different fracture types. A standard fixation surgery uses approximately 5-15 implant components, while revision procedures due to infection, implant failure, or delayed fracture healing occur in around 100,000-150,000 cases annually.
• External fixation devices support approximately 250,000-400,000 trauma procedures annually in India, particularly for open fractures, road accident injuries, and temporary stabilization of complex limb trauma. Major trauma centers generally stock 20-50 external fixation frame systems for emergency applications. Each procedure typically requires 4-10 fixation pins or wires, with external fixation frequently used in staged treatment approaches.
• Orthobiologics and synthetic bone grafts are utilized in approximately 300,000-500,000 trauma and reconstruction procedures annually in India. These products are mainly used for fracture non-unions, bone defects, and revision surgeries, with average graft usage ranging from 5-30 cc per procedure. Advanced orthopedic hospitals perform approximately 500-2,000 graft assisted trauma procedures annually, particularly for complex fracture healing.



India Trauma Devices Market By Surgical Site / Anatomical Location
• Upper extremity trauma devices are used in approximately 700,000-1 million surgical procedures annually in India, covering wrist, hand and forearm, clavicle, and humerus fractures. Distal radius fractures account for more than 250,000-400,000 treated cases annually, driven by falls, workplace injuries, and road accidents. Hospital stays generally range from 1-4 days, followed by rehabilitation programs lasting 4-12 weeks.
• Lower extremity trauma devices represent the largest application segment, supporting approximately 1.5-2 million procedures annually in India. Femur, tibia, ankle, and hip fractures contribute to millions of emergency trauma visits each year, particularly from road traffic accidents. Complex lower-limb fixation procedures typically require 5-12 days of hospitalization, with rehabilitation extending from 3-12 months.
• Pelvic trauma devices are utilized in approximately 100,000-180,000 surgical interventions annually in India. Pelvic and acetabular fractures generate approximately 300,000-500,000 trauma admissions annually, often linked to high impact accidents and industrial injuries. Operative pelvic fixation cases generally involve 10-20 days of hospitalization, followed by prolonged mobility rehabilitation.

India Trauma Devices Market By End User
• Hospitals are the primary users of trauma devices in India, supported by more than 70,000 hospitals and healthcare facilities, including public, private, and specialized trauma centers. These facilities perform the majority of India’s orthopedic trauma surgeries, with major trauma hospitals handling 5,000-15,000 trauma procedures annually. Large tertiary care centers typically maintain extensive implant inventories covering multiple fracture fixation categories.
• Ambulatory Surgical Centers perform approximately 150,000-300,000 orthopedic trauma-related procedures annually in India, mainly involving minor fracture fixation, implant removal, and outpatient orthopedic interventions. Individual ASCs typically complete 1,000-5,000 orthopedic procedures annually. Urban ASCs increasingly support short stay trauma treatment models with reduced hospitalization requirements.
• Orthopedic clinics manage approximately 20-30 million trauma related consultations annually across India, including fracture diagnosis, follow-up care, rehabilitation planning, and conservative trauma treatment. Individual orthopedic specialists commonly evaluate 50-100 trauma patients per week. Clinics provide long term monitoring through imaging, physiotherapy coordination, and implant follow-up services.

India Trauma Devices Market By Material Type
• Titanium and titanium alloy implants are utilized in approximately 1.5-2 million trauma procedures annually in India, making them the preferred choice for advanced fracture fixation. These materials are widely used in long bone fractures, pelvic reconstruction, and cranio maxillofacial trauma. Implant retention frequently exceeds 10 years, reducing the need for secondary removal procedures.
• Bioabsorbable materials are used in approximately 50,000-100,000 trauma procedures annually in India, particularly in pediatric fractures, sports injuries, and selected facial trauma applications. These implants gradually degrade over 12-36 months, reducing the requirement for removal surgeries. Adoption is concentrated in premium orthopedic hospitals and academic medical centers.
• Other materials, including cobalt chromium alloys, polymer composites, and hybrid biomaterials, are utilized in approximately 100,000-200,000 trauma and reconstruction procedures annually in India. These materials are mainly used for complex revision surgeries and specialized orthopedic applications. Large tertiary hospitals maintain dedicated stocks of advanced implant materials for complicated trauma cases.

Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Trauma Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Internal Fixation Devices
• External Fixation Devices
• Orthobiologics & Synthetic Bone Grafts
• Trauma Surgical Instruments & Accessories

By Surgical Site / Anatomical Location
• Upper Extremity Trauma Devices
• Lower Extremity Trauma Devices
• Pelvic Trauma Devices
• Cranio-Maxillofacial Trauma Devices

By End User
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Orthopedic Clinics

By Material Type
• Stainless Steel
• Titanium & Titanium Alloys
• Bioabsorbable Materials
• Other Materials